10 Small Caps With Big Double-Digit Gains

5. Savara Inc. (NASDAQ:SVRA)

Savara soared by 27.84 percent week-on-week, as investors positioned their portfolios ahead of business updates from its participation in two conferences this week.

According to the company, members of its management team will host one-on-one meetings and participate in fireside chats at the Piper Sandler 37th Annual Healthcare Conference on Tuesday, December 2, and at the Evercore ISI 8th Annual Healthcare Conference on Thursday, December 4.

Investors will closely watch out for updates about the company’s business, alongside cues about its outlook.

Earlier this month, Savara Inc. (NASDAQ:SVRA) announced that it widened its net loss attributable to shareholders by 21.9 percent to $29.56 million from $24.2 million in the same period last year.

Total operating expenses also grew by 14.7 percent to $30.25 million from $26.3 million year-on-year, amid 1.4 percent higher research and development costs related to its Molbreevi program.

Molbreevi is a recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) in Phase 3 development for autoimmune pulmonary alveolar proteinosis (autoimmune PAP).